<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08682484709802</udiDi>
    <basicUdiDi>B-08682484709802</basicUdiDi>
    <tradeName>Cell Screen 1-2-3</tradeName>
    <deviceName>Cell Screen 1-2-3</deviceName>
    <manufacturerName>RED CELL BİYOTEKNOLOJİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000026921</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030308</emdnCode>
    <emdnDescription>ANTIBODY 3 CELL SCREENING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RCRBCAS3</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-08T18:12:45.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682484709147</udiDi>
    <basicUdiDi>B-08682484709147</basicUdiDi>
    <tradeName>Cell Screen 1-2-3</tradeName>
    <deviceName>Cell Screen 1-2-3</deviceName>
    <manufacturerName>RED CELL BİYOTEKNOLOJİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000026921</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030308</emdnCode>
    <emdnDescription>ANTIBODY 3 CELL SCREENING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RCRBCAS3</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-08T18:11:49.053Z</lastUpdated>
  </row>
</eudamedExport>